Company Overview of Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. develops and manufactures human cells in the United States, Europe, Japan, and internationally. The company’s proprietary products include human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs), and custom iPSCs and iCell products (MyCell products). It offers iCell Cardiomyocytes, which are purified human heart cells that beat in a dish and behave just like the heart cells found in the human body for in vitro drug discovery, toxicity testing, and chemical safety, as well as in vivo cellular therapeutics research and development, and stem cell banking; and iCell Neurons that are purified human neurons typical of ...
525 Science Drive
Madison, WI 53711
Founded in 2004
Key Executives for Cellular Dynamics International, Inc.
Chairman and Chief Executive Officer
Founder and Vice Chairman
Co-Founder, Chief Scientific Officer, Director and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2015.
Cellular Dynamics International, Inc. Key Developments
Cellular Dynamics International, Inc. Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 11:30 AM
Oct 2 15
Cellular Dynamics International, Inc. Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-08-2015 11:30 AM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Emile F. Nuwaysir, Chief Operating Officer and Vice President of Research & Development, Manufacturing & Quality Systems.
SeouLin Bioscience Co., Ltd. to Distribute Cellular Dynamics International, Inc.'s Products in Korea
Aug 20 15
Cellular Dynamics International, Inc. announced an exclusive agreement with SeouLin Bioscience Co. Ltd., for the distribution of CDI's products in the Republic of Korea. Under the terms of the agreement, SeouLin Bioscience will distribute CDI's iCell® catalog of products. CDI's iCell products are human induced pluripotent stem cell (iPSC)-derived tissue cells, including cardiomyocytes, hepatocytes, and neurons, among others totaling up to 12 cell types, as well as special media if required. Under discussion is the expansion to distribute the MyCell® catalog of products. CDI's MyCell Products enable researchers to better understand the phenotypic underpinnings of a disease of interest, as they submit donor samples to CDI for the manufacture of iPSCs and tissue cells from them. In addition, MyCell Products are already available for diseases such as cardiac arrhythmias, Alzheimer's and Parkinson's diseases, drug-induced liver injury, and muscular dystrophies. As part of the agreement, SeouLin Bioscience will handle first-level technical support inquiries from its customers.
Cellular Dynamics International, Inc.(NasdaqGM:ICEL) dropped from Russell 2000 Index
May 7 15
Cellular Dynamics International, Inc. will be removed from Russell 2000 Index.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 30, 2015